Chemours Is Maintained at Equal-Weight by Barclays
Chemours Analyst Ratings
Take Care Before Diving Into The Deep End On The Chemours Company (NYSE:CC)
Chemours (NYSE:CC) Investors Are up 5.8% in the Past Week, but Earnings Have Declined Over the Last Five Years
巴克莱银行维持The Chemours(CC.US)持有评级,下调目标价至21美元
Barclays analyst Michael Leithead maintains $The Chemours(CC.US)$ with a hold rating, and adjusts the target price from $22 to $21.According to TipRanks data, the analyst has a success rate of 57.4%
Express News | Chemours : Barclays Cuts Target Price to $21 From $22
WHITE HOUSE HBCU INITIATIVE HONORS FOSSI WITH 2024 CHAIRMAN'S AWARD
Woodward Names Ron Charles Chief Human Resources Officer
Chemours Develops Cost-Effective Retrofit for R-134a Refrigerant in Cars, Supporting Global Phasedown
Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $23
Goldman Sachs analyst Duffy Fischer maintains $The Chemours(CC.US)$ with a hold rating, and adjusts the target price from $38 to $23.According to TipRanks data, the analyst has a success rate of 62.2%
How Is The Market Feeling About Chemours?
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Chemours (CC) Opens Cutting-Edge Facility for EV Batteries
Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors
The Chemours To Go Ex-Dividend On August 15th, 2024 With 0.25 USD Dividend Per Share
August 13th (Eastern Time) - $The Chemours(CC.US)$ is trading ex-dividend on August 15th, 2024.Shareholders of record on August 15th, 2024 will receive 0.25 USD dividend per share on September 13th, 2
Express News | Chemours - Opening of Cbic Facility at Chemours Discovery Hub in Newark, Delaware
Express News | Chemours Opens State-of-the-Art Battery Innovation Center to Accelerate the Evolution of Electric Vehicle Batteries
Express News | Chemours : Jefferies Cuts Target Price to $20 From $25
The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
The Analyst Landscape: 4 Takes On Chemours